[Retracted] Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma

Table 4

The correlation between RNF44 expression and clinicopathologic factors in the TCGA cohort.

Characteristics	Total (N)	Odds ratio (OR)	value
Age (>60 vs. ≤60)	373	0.629 (0.417–0.946)	0.026
Weight (kg) (>70 vs. ≤70)	346	0.639 (0.417–0.976)	0.039
Histologic grade (G3 and 4 vs. G1 and 2)	369	1.950 (1.272–3.009)	0.002
T stage (T3 and 4 vs. T1 and 2)	371	1.601 (0.998–2.589)	0.053
Pathologic stage (stage III & IV vs. stage I & II)	350	1.777 (1.096–2.910)	0.021
N stage (N1 vs. N0)	258	2.953 (0.373–60.136)	0.351
M Stage (M1 vs. M0)	272	1.015 (0.120–8.560)	0.988
AFP (ng/ml) (>400 vs. ≤400)	280	2.441 (1.384–4.396)	0.002

Note. The stages were graded according to AJCC7. RNF44: RING Finger protein 44; AJCC7: American Joint Committee on Cancer 7th edition.